Efficacy and Safety of AJU-S56 5% in Dry Eye Syndrome Patients

NCT06291194 · clinicaltrials.gov ↗
PHASE3
Phase
UNKNOWN
Status
396
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

AJU Pharm Co., Ltd.

Collaborators